Your session is about to expire
← Back to Search
mHealth + low-carb/ketogenic diet for Type 2 Diabetes
Study Summary
This trial will test a lifestyle intervention including diet and exercise, enhanced by self-monitoring health technologies, on weight and diabetes outcomes and diabetic complications in 60 overweight/obese adults with or without T2D. Renal function will be assessed using traditional and novel biomarkers, including novel metabolites and mitochondrial function.
- Type 2 Diabetes
- Diabetic Kidney Disease
- Cognitive Functioning
- Weight Loss
- Diabetes
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is registration open for this research endeavor?
"As per the clinicaltrials.gov database, this specific medical trial has now concluded its recruitment phase and is not seeking any further participants; though it was initially posted on June 3rd 2021 and last updated on July 1st 2022. Fortunately, there are more than 1500 other trials that require patients at present."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger